X-80022270-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001109878.2(TBX22):c.1A>G(p.Met1?) variant causes a start lost, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001109878.2 start_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX22 | NM_001109878.2 | c.1A>G | p.Met1? | start_lost, splice_region_variant | 2/9 | ENST00000373296.8 | NP_001103348.1 | |
TBX22 | NM_016954.2 | c.1A>G | p.Met1? | start_lost | 1/8 | NP_058650.1 | ||
TBX22 | NM_001109879.2 | c.-356A>G | splice_region_variant, 5_prime_UTR_variant | 2/9 | NP_001103349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX22 | ENST00000373294.8 | c.1A>G | p.Met1? | start_lost | 1/8 | 1 | ENSP00000362390 | P1 | ||
TBX22 | ENST00000373296.8 | c.1A>G | p.Met1? | start_lost, splice_region_variant | 2/9 | 5 | NM_001109878.2 | ENSP00000362393 | P1 | |
TBX22 | ENST00000476373.1 | n.122A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 3 | |||||
TBX22 | ENST00000626498.2 | c.1A>G | p.Met1? | start_lost, splice_region_variant, NMD_transcript_variant | 2/9 | 2 | ENSP00000487527 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
TBX22-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 04, 2022 | The TBX22 c.1A>G variant is predicted to disrupt the translation initiation site (Start loss). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.